Cost of Revenue in USD of AGILE THERAPEUTICS INC from 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Agile Therapeutics Inc quarterly/annual Cost of Revenue history and change rate from 2020 to Q2 2024.
  • Agile Therapeutics Inc Cost of Revenue for the quarter ending 30 Jun 2024 was $1.5M, a 35.2% decline year-over-year.
  • Agile Therapeutics Inc Cost of Revenue for the twelve months ending 30 Jun 2024 was $7.84M, a 6.17% increase year-over-year.
  • Agile Therapeutics Inc annual Cost of Revenue for 2023 was $8.98M, a 31.3% increase from 2022.
  • Agile Therapeutics Inc annual Cost of Revenue for 2022 was $6.84M, a 36.2% decline from 2021.
  • Agile Therapeutics Inc annual Cost of Revenue for 2021 was $10.7M, a 3701% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.84M $1.5M -$811K -35.2% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $8.66M $1.68M -$323K -16.1% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $8.98M $2.19M +$538K +32.5% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $8.44M $2.48M +$1.05M +73.8% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $7.39M $2.31M +$76K +3.41% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $7.31M $2M +$476K +31.2% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $6.84M $1.65M -$4.05M -71% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $10.9M $1.43M -$1.29M -47.4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $12.2M $2.23M +$1.09M +94.8% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $11.1M $1.53M +$366K +31.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $10.7M $5.7M 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 $2.71M 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $1.15M 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $1.16M 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022

AGILE THERAPEUTICS INC Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.98M +$2.14M +31.3% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 $6.84M -$3.88M -36.2% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $10.7M +$10.4M +3701% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 $282K 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.